Modulation of gene methylation by genistein or lycopene in breast cancer cells

Environmental and Molecular Mutagenesis

Volumn 49, Issue 1, 2008, Pages 36-45

  King Batoon, Audrey ^a   Leszczynska, Joanna M ^a   Klein, Catherine B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; DNA methylation; Genistein; GSTP1; HIN 1; Lycopene; RAR

Indexed keywords

GENISTEIN; LYCOPENE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CAROTENOIDS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; GLUTATHIONE S-TRANSFERASE PI; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

LYCOPERSICON ESCULENTUM;

EID: 39749140314     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20363     Document Type: Article

References (74)

1. Adlercreutz H. 2002. Phytoestrogens and cancer. Lancet Oncol 3:364-373.
2. Arai T, Miyoshi Y, Kim SJ, Taguchi T, Tamaki Y, Noguchi S. 2006. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 100:169-176.
3. Batoon AK, Leszczynska J, Klein CB. 2007. Mechanisms underlying prevention of genomic instability in breast tumor cells by genistein and lycopene. Environ Mol Mutagen 48:618 Abs. P116.
4. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, Levy J. 2005. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4:177-186.
5. Bisogna M, Calvano JE, Ho GH, Orlow I, Cordon-Cardo C, Borgen PI, Van Zee KJ. 2001. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Cancer Genet Cytogenet 125:131-138.
6. Bloedon L, Jeffcoat RA, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH. 2002. Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am J Clin Nutr 76:1126-1137.
7. Bradlow HL, Sepkovik DW. 2002. Diet and breast cancer. Ann N Y Acad Sci 963:247-267.
8. Cailleau R, Olive M, Cruciger QV. 1978. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14:911-915.
9. Calaf G, Russo J. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483-492.
10. Chalabi N, Delort L, LeCorre L, Satih S, Bignon Y-J, Bernard-Gallon DJ. 2006. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7:663-672.
11. Chalabi N, Satih S, Delort L, Bignon Y-J, Bernard-Gallon DJ. 2007a. Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim Biophys Acta 1769:124-130.
12. Chalabi N, Delort L, Satih S, Dechelotte P, Bignon Y-J, Bernard-Gallon DJ. 2007b. Immunohistochemical expression of RARα, RARβ, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR. J Histochem Cytochem 55:877-883.
13. Chang C, Churchwell MI, Delcos KB, Newbold RR, Doerge DR. 2000. Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 130:1963-1970.
14. Cowell JK, LaDuca J, Rossi MR, Burkhardt T, Nowak NJ, Matsui S. 2005. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 163:23-29.
15. Davis CD, Ross SA. 2007. Dietary components impact histone modifications and cancer risk. Nutr Rev 65:88-94.
16. Day JK, Besch-Williford C, McMann TR, Hufford MG, Lubahn DB, MacDonald RS. 2001. Dietary genistein increased DMBA-induced mammary adenocarcinomas in wild-type, but not ER alpha KO, mice. Nutr Cancer 39:226-232.
17. Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, Newton LG, Nehra V, Forsee KM, MacDonald RS, Besch-Williford C, Huang TH, Lubahn DB. 2002. Genistein alters methylation patterns in mice. J Nutr 132:2419S-2423S.
18. De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, Albini A. 2001. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res 480-481:9-22.
19. Di Mascio P, Kaiser S, Sies H. 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532-538.
20. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114:567-572.
21. Ellinger S, Ellinger J, Stehle P. 2006. Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: Do we have the evidence from intervention studies? Curr Opin Clin Nutr Metab Care 9:722-727.
22. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. 1998. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58:4515-4518.
23. Fang M, Chen D, Yang CS. 2007. Dietary polyphenols may affect DNA methylation. J Nutr 137:223S-228S.
24. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11:7033-7041.
25. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R. 2002. Retinole acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 13:335-341.
26. Ferguson LR, Philpott M, Karunasinghe N. 2004. Dietary cancer and prevention using antimutagens. Toxicology 198:147-159.
27. Fukushima S, Takada N, Hori T, Wanibuchi H. 1997. Cancer prevention by organosulfur compounds from garlic and onion. J Cell Biochem 27:100-105.
28. Grunt TW, Tomek K, Wagner R, Puckmair K, Zielinski CC. 2007. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells. Differentiation 75:883-890.
29. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
30. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R. 1999. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6:1089-1095.
31. Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y. 2007. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells. Breast Cancer Res Treat 104:221-230.
32. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ. 2001. Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area Breast Cancer Study. Am J Epidemiol 154:434-441.
33. Jhaveri MS, Morrow CS. 1998. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene 210:1-7.
34. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y. 2000. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36:101-111.
35. Kavanaugh CJ, Trumbo PR, Ellwood KC. 2007. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: Tomatoes, lycopene, and cancer. J Natl Cancer Inst 99:1074-1085.
36. Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH. 2004. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79:282-288.
37. King A, Leszczynska J, Hickey CA, Klein CB. 2006. Prevention of spontaneous and X-ray induced genomic instability in breast cancer cells by the dietary antimutagens genistein and lycopene. Environ Mol Mutagen 47:425.
38. King AA, Shaughnessy DT, Mure K, Ward WO, Umbach DM, Xu Z, Ducharme D, Taylor JA, DeMarini DM, Klein CB. 2007. Antimutagenicity of cinnamaldehyde and vanillin in human cells: Global gene expression and possible role of DNA damage and repair. Mutat Res 616:60-69.
39. Klein CB, King AA. 2007. Genistein genotoxicity: Critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol 224:1-11.
40. Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. 2005. HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res 65:9659-9669.
41. Kune G, Watson L. 2006. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer 56:11-21.
42. Lamartiniere CA. 2000. Protection against breast cancer with genistein: A component of soy. Am J Clin Nutr 7:1705S-1707S.
43. Lee JS. 2007. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch 450:637-642.
44. Lee WJ, Shim J-Y, Zhu BT. 2005. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68:1018-1030.
45. Marchetti A, Barassi F, Martella C, Chella A, Salvatore S, Castrataro A, Mucilli F, Sacco R, Buttitta F. 2004. Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 10:1338-1343.
46. Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin WJ Jr. 1999. Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors. J Nutr 129:849-854.
47. Mayne ST, Cartmel B, Lin H, Zheng T, Goodwin WJ. 2004. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx, and larynx cancers. J Am Coll Nutr 23:34-42.
48. Milner JA. 2001. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492:69-81.
49. Miltyk W, Craciunescu CN, Fisher L, Jeffcoat RA, Koch MA, Lopaczynski W, Mahoney C, Crowell J, Paglieri J, Zeisel SH. 2003. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr 77:875-882.
50. Mortensen A, Skibsted LH, Sampson J, Rice-Evans C, Everett SA. 1997. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett 418:91-97.
51. Mure K, Rossman TG. 2001. Reduction of spontaneous mutagenesis in mismatch repair-deficient and proficient cells by dietary antioxidants. Mutat Res 480-481:85-95.
52. Mure K, Plewa MJ, Takeshita T, Rossman TG, Klein CB. 2006. Analysis of the ability of individual isofavones in soybean-processing by-product mixtures to reduce spontaneous mutation in mismatch-repair deficient cells. Environ Mol Mutagen 47:Abs. P134.
53. Myzak MC, Karplus PA, Chung FL, Dashwood RH. 2004. A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase. Cancer Res 64:5767-5774.
54. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. 2006. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 27:811-819.
55. Prawan A, Keum Y-S, Khor TO, Yu S, Nair S, Li W, Hu L, Kong ANT. 2007. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharm Res [Epub ahead of print].
56. Rao AV, Rao LG. 2007. Carotenoids and human health. Pharmacol Res 55:207-216.
57. Safford B, Dickens A, Halleron N, Briggs D, Carthew P, Baker V. 2003. A model to estimate the oestrogen receptor mediated effects from exposure to soy isoflavones in food. Regul Toxicol Pharmacol 38:196-209.
58. Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Mariscal I, Chavez A, Acuna C, Salazar AM, Lizano M, Duenas-Gonzalez A. 2003. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res 9:1596-1603.
59. Singletary K, Ellington A. 2006. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells. Anticancer Res 26:1039-1048.
60. Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R, Toma S, Nicolo G, Sacchi N. 2002. Endogenous reactivation of the RAR-beta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62:2455-2461.
61. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
62. Thomson CA, Stendell-Hollis NR, Rock CL, Cussler EC, Flatt SW, Pierce JP. 2007. Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 16:2008-2015.
63. Tamimi RM, Hankinson SE, Campos H, Spiegelman D, Zhang S, Colditz GA, Willett WC, Hunter DJ. 2005. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161:153-160.
64. Van Erp-Baart MAJ, Brants HAM, Kiely M. 2003. Isoflavone intake in four different European countries: The VENUS approach. Br J Nutr 89:25-30.
65. Watson WH, Cai J, Jones DP. 2000. Diet and apoptosis. Annu Rev Nutr 20:485-505.
66. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG. 1997. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 57:4158-4161.
67. Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G, Marth C. 2000. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer. J Natl Cancer Inst 92:826-832.
68. Widschwendter M, Berger J, Muller HM, Zeimet AG, Marth C. 2001. Epigenetic downregulation of the retinoic acid receptor-β2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6:193-201.
69. Wiseman H, Casey K, Bowey EA, Duffy R, Davies M, Rowland IR, Lloyd AS, Murray A, Thompson R, Clarke DB. 2004. Influence of 10 wk soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora in healthy adults. Am J Clin Nutr 80:692-699.
70. Wu AH, Wan P, Hankin J, Tseng C-C, Yu MC, Pike MC. 2002. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491-1496.
71. Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC. 1995. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71:1353-1358.
72. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosental JF, Hyer MB. 1993. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819-1827.
73. Zhang Y, Wang G-J, Song TT, Murphy PA, Hendrich S. 1999. Urinary disposition of the soybean isoflavones daidzein, genistein, and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 129:957-962.
74. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61:249-255.